The Korean Clinical Research Center for End-Stage Renal Disease Study Validates the Association of Hemoglobin and Erythropoiesis-Stimulating Agent Dose with Mortality in Hemodialysis Patients

BACKGROUND: Anemia is an important risk factor for mortality in hemodialysis (HD) patients. However, higher hemoglobin (Hb) is not necessarily better, as seen in several studies. This study aimed to validate the clinical use of an Hb target of 10–11 g/dL in Korean HD patients. METHODS: A total of 1,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Owen, Jang, Hye Min, Jung, Hee-Yeon, Kim, Yon Su, Kang, Shin-Wook, Yang, Chul Woo, Kim, Nam-Ho, Choi, Ji-Young, Cho, Jang-Hee, Kim, Chan-Duck, Kim, Yong-Lim, Park, Sun-Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599895/
https://www.ncbi.nlm.nih.gov/pubmed/26452232
http://dx.doi.org/10.1371/journal.pone.0140241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599895/
https://www.ncbi.nlm.nih.gov/pubmed/26452232
http://dx.doi.org/10.1371/journal.pone.0140241

Ejemplares similares